| Vol. 8.21 – 20 June, 2022 |
| |
|
|
| Scientists proposed an approach for the scalable and automated preparation of highly hair-inductive tissue grafts using a bioprinter. [Acta Biomaterialia] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
| DERMAL STEM CELLS & TISSUE REGENERATION |
|
|
|
| The dominant-negative mutant of Cdc42 was used to explore the role of Cdc42 in activin B-induced adipose-derived mesenchymal stem cell migration, proliferation, and secretion in vitro. [Stem Cell Research & Therapy] |
|
|
|
| Investigators studied the metabolome, epigenome, and transcriptome of human keratinocytes exposed to ultraviolet B (UVB) with or without sulforaphane using liquid chromatography–mass spectroscopy, DNA methylation sequencing, and RNA sequencing. [Chemical Research in Toxicology] |
| |
|
|
| Human psoriasis skin and primary human keratinocyte were detected in vitro. Epidermis specific transgenic mouse strain was used to further investigate psoriasis-like skin inflammation in vivo. [Cell Proliferation] |
|
|
|
| Combined analysis of microarray data and single-cell RNA sequencing data revealed the key interactions between immune cells in the melanoma microenvironment. [Scientific Reports] |
|
|
|
| The inhibitory effects of IDF-11774, an inhibitor of HIF-1α, on melanoma growth and metastasis were examined using cultured B16F10 mouse melanoma cells and nude mice transplanted with B16F10 melanoma cells in the presence or absence of CoCl2-induced hypoxia. [Biomolecules & therapeutics] |
|
|
|
| Researchers explored the potential relationship between melanoma and hypoxia‑related long non-coding RNAs and demonstrated that MIR205HG could promote melanoma cell proliferation partly via the canonical Wnt/β‑catenin signaling pathway. [Molecular Medicine Reports] |
|
|
|
|
| The authors introduce an update on the progress of microneedles (MNs) as an innovative strategy for melanoma, especially when combining MNs with different therapies against melanoma. [Journal of Controlled Release] |
|
|
|
|
| The US FSA approved Olumiant oral tablets to treat adult patients with severe alopecia areata, marking the first FDA approval of a systemic treatment for alopecia areata. [FDA] |
|
|
|
| VYNE Therapeutics, announced the completion of enrollment in the Phase IIa study of FMX114 for the treatment of mild-to-moderate atopic dermatitis. [VYNE Therapeutics Inc.] |
|
|
|
|
| December 8 – 10, 2022 Los Angeles, California, United States |
|
|
|
|
|
| University College Dublin – Dublin, Ireland |
|
|
|
| Washington University School of Medicine – St. Louis, Missouri, United States |
|
|
|
| Columbia University – New York City, New York, United States |
|
|
|
| NTU Lee Kong Chian School of Medicine – Singapore, Singapore |
|
|
|
| Baylor College of Medicine – Houston, Texas, United States |
|
|
|
|